Clinical Scorecard: Caspases in Sepsis: Understanding Programmed Cell Death Mechanisms, Pathophysiology, and Potential Therapeutic Approaches

At a Glance

Key Highlights

• Sepsis is characterized by organ impairment due to uncontrolled systemic reactions to infection.
• Caspases play a central role in regulating various PCD modalities linked to sepsis.
• Dysregulated PCD contributes to immune dysregulation and organ damage in sepsis.
• Therapeutic strategies targeting caspases may provide novel treatment avenues for sepsis.
• Sepsis-related mortality has surged, particularly linked to COVID-19.

Guideline-Based Recommendations

Diagnosis

• Utilize Sepsis-3 definitions emphasizing immune-inflammatory dysregulation.

Management

• Implement basic interventions such as fluid resuscitation and anti-infection strategies.

Monitoring & Follow-up

• Monitor for complications like acute lung injury, acute kidney injury, and encephalopathy.

Risks

• Consider risks associated with multidrug-resistant bacteria and treatment-related adverse events.

Patient & Prescribing Data

Individuals diagnosed with sepsis, particularly those experiencing organ dysfunction.

Current treatment focuses on basic interventions, with ongoing exploration of caspase-targeted therapies.

Clinical Best Practices

• Early identification and standardized management of sepsis are critical.
• Maintain organ function and modulate inflammation as part of sepsis care.

Related Resources & Content

• Sepsis-3 Definitions
• Global Burden of Sepsis